UBS Group AG - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 74 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$13,080
+161.6%
72,662
+506.2%
0.00%
Q3 2022$5,000
+66.7%
11,986
+2196.2%
0.00%
Q1 2022$3,000
-99.7%
522
-99.5%
0.00%
Q4 2021$1,028,000
-29.4%
106,204
+30.4%
0.00%
Q3 2021$1,457,000
+70.8%
81,470
+133.2%
0.00%
Q2 2021$853,000
-7.8%
34,933
+0.1%
0.00%
Q1 2021$925,000
+4104.5%
34,911
+1112.2%
0.00%
Q4 2020$22,000
+340.0%
2,880
+188.0%
0.00%
Q3 2020$5,000
-64.3%
1,000
-56.3%
0.00%
Q2 2020$14,000
-75.0%
2,288
-82.0%
0.00%
Q1 2020$56,000
-84.2%
12,714
-65.8%
0.00%
Q4 2019$354,000
+353.8%
37,222
+273.7%
0.00%
Q3 2019$78,0009,961
+43208.7%
0.00%
Q1 2019$0
-100.0%
23
-99.2%
0.00%
Q3 2018$69,0002,8680.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,296,526$290,671,0005.29%
HARBOURVEST PARTNERS LLC 986,878$7,490,0002.93%
Abbot Financial Management, Inc. 537,000$4,076,0002.35%
Artal Group S.A. 3,778,913$28,682,0000.62%
HITE Hedge Asset Management LLC 88,740$674,0000.16%
Virtus ETF Advisers LLC 33,793$256,0000.11%
JACOBS LEVY EQUITY MANAGEMENT, INC 394,909$2,997,0000.03%
Baillie Gifford 4,710,061$35,749,0000.02%
Caption Management, LLC 86,000$652,0000.02%
Blueshift Asset Management, LLC 14,626$111,0000.01%
View complete list of RUBIUS THERAPEUTICS INC shareholders